![]() |
市场调查报告书
商品编码
1819999
2025-2033 年家庭输液治疗市场报告(按产品、应用和地区)Home Infusion Therapy Market Report by Product, Application, and Region 2025-2033 |
2024年,全球家庭输液治疗市场规模达454亿美元。展望未来, IMARC Group预计到2033年,市场规模将达到708亿美元,2025-2033年期间的复合年增长率(CAGR)为5.1%。老年人口的成长以及人们对家庭医疗保健的日益偏好,正在推动市场的发展。
先进输液技术的采用日益增多
技术进步正在透过引入智慧输液帮浦和安全软体来增强家庭输液治疗,从而提高精准度、安全性和效率。这些创新有助于减少用药错误,提供更完善的监测,并与数位系统无缝集成,从而简化患者的家庭护理并减轻护理人员的负担。例如,2024年4月,百特的Novum IQ大容量输液帮浦和Dose IQ安全软体获得美国FDA批准,透过提供整合式智慧型帮浦解决方案来增强居家输液治疗。这项进展提高了患者的安全性和效率,解决了临床医生的工作量挑战,并推进了互联医疗。
专业输液服务需求不断成长
随着越来越多的患者需要复杂的慢性病治疗,对专业输液服务的需求也日益增长。此外,这些服务提供居家客製化治疗,从而减少患者就诊需求。此外,这种个人化方法有助于有效管理长期疾病,同时提高患者舒适度和治疗效果。例如,Dynamic Access 于 2024 年 2 月推出了 Dynamic Infusion,这是一家专业的家庭输液护理服务提供商,为自体免疫疾病和多发性硬化症等慢性病患者提供服务。此外,他们还与 35 多家专业药局合作,每年在九个州提供超过 10,000 次上门服务,提升病患照护水准。
数位健康工具的整合
数位工具与居家输液治疗的整合,使得医疗服务提供者和患者之间能够更好地监测患者病情,并实现即时资料共享。此外,这些系统还能提供对治疗进展的洞察,从而增强远距护理管理,提高依从性,方便调整治疗计划,同时最大限度地减少面对面咨询的需求。例如,2024年5月,穆格公司专为居家输液治疗设计的CURLIN 8000行动输液系统获得美国FDA核准。该系统提供精准的多疗法输液和直觉的用户介面,并与CURLIN RxManager集成,增强了家庭护理药剂师和患者的安全性和可控性。
The global home infusion therapy market size reached USD 45.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 70.8 Billion by 2033, exhibiting a growth rate (CAGR) of 5.1% during 2025-2033. The growing elderly population, along with the increasing preference for home healthcare, is propelling the market.
Increasing Adoption of Advanced Infusion Technology
Technological advancements are enhancing home infusion therapy by introducing smart infusion pumps and safety software that improve precision, safety, and efficiency. In contrast, these innovations help to reduce medication errors, offer better monitoring, and provide seamless integration with digital systems, thereby streamlining home-based care for patients and reducing the burden on caregivers. For instance, in April 2024, Baxter received U.S. FDA clearance for its Novum IQ large volume infusion pump and Dose IQ Safety Software, thereby enhancing home infusion therapy by offering integrated smart pump solutions. This development boosts patient safety and efficiency, addressing clinician workload challenges and advancing connected care.
Growing Demand for Specialized Infusion Services
The need for specialized infusion services has grown as more patients require complex treatments for chronic conditions. In addition, these services provide tailored therapies delivered in a home setting, thereby reducing the need for hospital visits. Furthermore, this personalized approach helps to manage long-term illnesses effectively while improving patient comfort and treatment outcomes. For instance, in February 2024, Dynamic Access launched dynamic infusion, a specialty home infusion nursing provider, which is serving patients with chronic conditions like autoimmune disorders and multiple sclerosis. Also, they partnered with 35+ specialty pharmacies, offering over 10,000 home visits annually across nine states, enhancing patient care.
Integration of Digital Health Tools
The integration of digital tools in home infusion therapy is enabling better patient monitoring and real-time data sharing between healthcare providers and patients. Moreover, these systems enhance remote care management by offering insights into therapy progress, thereby improving adherence and facilitating adjustments to treatment plans while minimizing the need for in-person consultations. For instance, in May 2024, Moog received U.S. FDA clearance for the CURLIN 8000 ambulatory infusion system, designed specifically for home infusion therapy. This system offers precise multi-therapy infusions and intuitive user interfaces and integrates with CURLIN RxManager, enhancing safety and control for home care pharmacists and patients.
Infusion pumps currently hold the largest home infusion therapy market demand
Infusion pumps exhibit a clear dominance in the market due to their precision in medication delivery, as they offer defined medication delivery and enhancing patient care. For example, Baxter launched its advanced Spectrum IQ pump, thereby improving patient safety and remote monitoring capabilities for home-based care.
Anti-infectives currently hold the largest home infusion therapy market statistics
Anti-infectives lead the market due to their increased use in treating severe infections, such as pneumonia, with intravenous antibiotics. For instance, Smiths Medical's CADD infusion system facilitates precise delivery and supports increased adoption.
North America currently dominates the infusion therapy market revenue
The home infusion therapy market outlook has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
As per the home infusion therapy market overview, North America dominates the market, which is driven by advanced healthcare infrastructure and increasing demand for home-based treatments. Moreover, the region benefits from a growing elderly population and rising chronic disease cases, prompting more home infusion therapies. For example, CVS Health expanded its home infusion services, thereby enhancing access to these treatments across the U.S. Furthermore, high demand for at-home care, alongside supportive reimbursement policies and technological advancements, further strengthens the region's dominance in this market.